Entities / Company
Aligos Therapeutics, Inc..
Company
- Reports this week
- 1
- Active events
- 1
- Connections
- 29
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
Aligos Therapeutics is expanding its study abroad, gaining regulatory approvals in multiple countries including China, Moldova, Canada, Taiwan, and New Zealand.Some support1 report
-
Context Therapeutics Inc. began using LinkedIn for public communication.Some support2 reports
-
Ramón Polo was appointed SVP at Aligos Therapeutics, Inc., having previously worked at Johnson & Johnson.Some support1 report
-
Aligos Therapeutics, Inc. utilized LinkedIn for sharing company updates.Some support4 reports
-
Aligos Therapeutics, Inc. presented at a meeting held in Berlin.Some support1 report
-
Aligos Therapeutics presented data at the annual European Association for the Study of the Liver congress in Barcelona.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Aligos Therapeutics, Inc. this week
News at the entities that move Aligos Therapeutics, Inc. most-
mash OperationalWave Life Sciences is developing WVE-007, an investigational GalNAc-siRNA product, for MASH indications.Moves Aligos Therapeutics, Inc.
-
LinkedIn OperationalBoth LinkedIn and Google are currently being utilized as platforms for news distribution.Moves Aligos Therapeutics, Inc.
-
South San Francisco Shared contextClaris moved its headquarters from Jersey City to South San Francisco and appointed new leadership.Moves Aligos Therapeutics, Inc.
-
Cantor Fitzgerald Mentioned togetherAnalyst firm lowered price targets on Automatic Data Processing (ADP) stock on June 6, 2026.Moves Aligos Therapeutics, Inc.
-
Amsterdam Shared contextColonial history is noted to date back to the 17th century, involving England and Amsterdam.Moves Aligos Therapeutics, Inc.
-
Europe Shared contextThe European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Moves Aligos Therapeutics, Inc.
Connections
The 7 strongest of 29, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
European Association for the Study of the Liver Operational
they act on each other directly
-
LinkedIn Operational
Aligos Therapeutics utilizes LinkedIn as a platform for public communication and company information sharing.
-
mash Operational
Aligos Therapeutics is actively developing therapies specifically designed to treat MASH subjects.
-
Amsterdam Shared context
Aligos Therapeutics presented research at a congress held in Amsterdam.
-
Europe Shared context
Aligos Therapeutics operates and retains rights within the European markets.
-
South San Francisco Shared context
Aligos Therapeutics, Inc. is headquartered in South San Francisco.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald provided market coverage and reaffirmed an overweight rating for Aligos Therapeutics.
History
Events by the month they beganSeptember 2026
2 eventsJuly 2026
1 eventJune 2026
7 events- Cantor Fitzgerald reiterated an Overweight rating for aTyr Pharma on August 20, 2025.
- Aligos Therapeutics is expanding its study abroad, gaining regulatory approvals in multiple countries including China, Moldova, Canada, Taiwan, and New Zealand.
- Context Therapeutics Inc. began using LinkedIn for public communication.
- Ramón Polo was appointed SVP at Aligos Therapeutics, Inc., having previously worked at Johnson & Johnson.
- Aligos Therapeutics, Inc. utilized LinkedIn for sharing company updates.
- Aligos Therapeutics, Inc. presented at a meeting held in Berlin.
- Aligos Therapeutics presented data at the annual European Association for the Study of the Liver congress in Barcelona.